Skip to main content

Table 3 Indicators of performance of the Mantoux test and IPT

From: Inequality in uptake of isoniazid prevention therapy and Mantoux test among pregnant women with HIV in the Eastern Cape, South Africa

Variables

Performed

Not Performed

p-value

n (%)

n (%)

Mantoux Test by study sites

 Frere hospital (n = 608)

363 (59.7)

245 (40.3)

<0.001

 Cecilia Makiwane hospital (n = 711)

379 (53.3)

332 (46.7)

 

 Bisho hospital (n = 319)

32 (10.0)

287 (90.0)

 

Mantoux Test by type of residence

 Rural (n = 564)

220 (39.0)

344 (61.0)

<0.001

 Semi-urban (n = 755)

381 (50.5)

374 (49.5)

 

 Urban (n = 319)

173 (54.2)

146 (45.8)

 

INH prophylaxis by study sites

 Frere hospital (n = 631)

511 (81.0)

120 (19.0)

<0.001

 CMH (n = 706)

592 (83.8)

117 (16.2)

 

 Bisho (n = 315)

206 (65.4)

109 (34.6)

 

INH Prophylaxis by type of residence

 Rural (n = 568)

424 (74.6)

144 (25.4)

0.004

 Semi-urban (n = 760)

622 (81.8)

138 (18.8)

 

 Urban (n = 324)

263 (81.2)

61 (18.8)

 
  1. INH=Isoniazid; Missing data were excluded from the analysis (there were missing data for 71 participants on Mantoux test and 57 missing data on INH Prophylaxis)